Peritonitis Clinical Trials

11 recruitingLast updated: May 11, 2026

There are 11 actively recruiting peritonitis clinical trials across 8 countries. Studies span Not Applicable, Phase 3, Phase 4, Phase 2. Top locations include Tanta, Egypt, Amiens, France, Banhā, Qalyubia Governorate, Egypt. Updated daily from ClinicalTrials.gov.


Peritonitis Trials at a Glance

11 actively recruiting trials for peritonitis are listed on ClinicalTrialsFinder across 6 cities in 8 countries. The largest study group is Not Applicable with 5 trials, with the heaviest enrollment activity in Tanta, Amiens, and Banhā. Lead sponsors running peritonitis studies include RWTH Aachen University, Tanta University, and Centre Hospitalier Universitaire de Nice.

Browse peritonitis trials by phase

Treatments under study

About Peritonitis Clinical Trials

Looking for clinical trials for Peritonitis? There are currently 3 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Peritonitis trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Peritonitis clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 111 of 11 trials

Recruiting

Capillary Leak Index Versus Conventional Biomarkers in Predicting Sepsis-Related Outcomes

Peritonitis Infectious
Benha University100 enrolled1 locationNCT07232342
Recruiting
Not Applicable

Role of Protective Stoma After Primary Anastomosis for Generalized Peritonitis Due to Perforated Diverticulitis

Peritonitis
University Hospital, Rouen204 enrolled20 locationsNCT04604730
Recruiting
Phase 2

Prospective, Randomized Trial of Personalized Medicine With Pentaglobin® After Surgical Infectious Source Control in Patients With Peritonitis

SepsisSeptic ShockPeritonitis
RWTH Aachen University200 enrolled20 locationsNCT03334006
Recruiting
Not Applicable

Benefit of Hypnosis on Smartphone for Acute Post-operative Pain (HYPNO-APP)

Appendicitis With Peritonitis
Centre Hospitalier Universitaire de Nice20 enrolled1 locationNCT05854914
Recruiting
Not Applicable

Efficacy of Conventional Dose Protocol vs Low Dose Protocol Albumin Use in Patients With Cirrhosis and High Risk Spontaneous Bacterial Peritonitis

Liver CirrhosisSpontaneous bacterial peritonitis
Institute of Liver and Biliary Sciences, India300 enrolled1 locationNCT06026267
Recruiting
Phase 4

Oral Vitamin D Supplementation Prevent Peritoneal Dialysis-related Peritonitis

Vitamin D DeficiencyPeritoneal Dialysis-associated Peritonitis
Peking University First Hospital176 enrolled1 locationNCT05860270
Recruiting
Phase 4

Clinical Trial on Antibiotic-Lock in Tenckhoff Catheter for Relasping and Repeat Peritonitis

Peritoneal Dialysis-associated Peritonitis
Alice Ho Miu Ling Nethersole Hospital46 enrolled1 locationNCT05971537
Recruiting
Not Applicable

Vacuum Assisted Closure Versus On-demand Relaparotomy in Patients With Fecal or Diffuse Peritonitis

Fecal PeritonitisSecondary PeritonitisDiffuse; Peritonitis
Odense University Hospital340 enrolled1 locationNCT03932461
Recruiting
Not Applicable

Fasciotens to Treat an Open Abdomen - a Prospective Cohort Study

Pancreatitis, Acute NecrotizingIntraabdominal HypertensionAbdominal Compartment Syndrome+1 more
RWTH Aachen University15 enrolled1 locationNCT04033614
Recruiting
Phase 3

Oral Gemifloxacin Versus Intravenous Cefotaxime in Treatment of Spontaneous Bacterial Peritonitis

Spontaneous bacterial peritonitis
Tanta University60 enrolled1 locationNCT04168099
Recruiting
Phase 3

Norfloxacin With Itopride Versus Norfloxacin in Secondary Prophylaxis of Spontaneous Bacterial Peritonitis

Spontaneous bacterial peritonitis
Tanta University80 enrolled1 locationNCT04161768